Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.

Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. — المؤلف: Azoulay, Elie — JAMA 20181228

المؤلف
Azoulay, Elie
النشر
JAMA 20181228
الوصف
2099-2107 p.
الموضوعات
Adult؛ Aged؛ Critical Illness؛ Female؛ High-Frequency Ventilation؛ Humans؛ Immunocompromised Host؛ Male